MetaADEDB 2.0 @ LMMD
Bromazepam
(VMIYHDSEFNYJSL-UHFFFAOYSA-N)
Structure
SMILES
O=C1CN=C(c2c(N1)ccc(c2)Br)c1ccccn1
Type(s)
Approved; Illicit; Investigational
ATC code(s)
N05BA08
Molecular Formula:
C14H10BrN3O
Molecular Weight:
316.153
Log P:
2.2072
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
1
TPSA:
54.35
CAS Number(s):
1812-30-2
Synonym(s)
1.
Bromazepam
External Link(s)
PubChem Compound2441
ChEBI31302
CHEMBLCHEMBL277062
DrugBankDB01558
DrugCentral399
KEGGdr:D01245
Therapeutic Target DatabaseD0E3FD
ZINC1051
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug DependenceFAERS: 1US FAERS
2Suicide attemptFAERS: 1US FAERS
3AcidosisOFFSIDES
4Acute respiratory failureOFFSIDES
5AdenomaOFFSIDES
6Adverse eventOFFSIDES
7AgitationSIDER
8Alanine Aminotransferase IncreasedOFFSIDES
9Alertness decreasedSIDER
10Altered state of consciousnessOFFSIDES
11Anaphylactic shockSIDER
12AngerSIDER
13Anorectal cellulitisOFFSIDES
14AnorexiaOFFSIDES
SIDER
15Anti-erythropoietin antibody positiveOFFSIDES
16AnuriaOFFSIDES
17Anxiety Disorders2764184
4836379		CTD
18AnxietyOFFSIDES
19AstheniaOFFSIDES
SIDER
20Ataxia4836379CTD
SIDER
21Atrial tachycardiaOFFSIDES
22Blood alkaline phosphatase increasedOFFSIDES
23Blood cholesterol abnormalOFFSIDES
24Blood glucose decreasedSIDER
25Blood sodiumOFFSIDES
26BradycardiaOFFSIDES
27Cardiac ArrestSIDER
28Cardiovascular insufficiencyOFFSIDES
29CholangiolitisOFFSIDES
30ChromaturiaOFFSIDES
31Completed SuicideCanada Vigilance: 2Canada Vigilance
32Compression stockings applicationOFFSIDES
33ConfabulationOFFSIDES
34Confusion2068441CTD
35Crush syndromeOFFSIDES
36Cytolytic hepatitisOFFSIDES
37Delirium6113557CTD
38Depressed Level of ConsciousnessSIDER
39Depressive disorder2764184CTD
40DermatitisSIDER
41Diabetes mellitus inadequate controlOFFSIDES
42DiplopiaSIDER
43Disorders of Excessive Somnolence4836379CTD
44DizzinessSIDER
45DrowsinessOFFSIDES
SIDER
46Dry skinOFFSIDES
47Duodenal UlcerOFFSIDES
48DyspepsiaSIDER
49Dystonia1292648CTD
50Echocardiogram abnormalOFFSIDES
51Emotional disorderSIDER
52Endocarditis enterococcalOFFSIDES
53EpicondylitisOFFSIDES
54ErythemaOFFSIDES
55Escherichia sepsisOFFSIDES
56Euphoric moodSIDER
57ExcitabilitySIDER
58FatigueSIDER
59Febrile bone marrow aplasiaOFFSIDES
60Feeling abnormalSIDER
61Fibroadenoma of breastOFFSIDES
62FractureSIDER
63GalactorrheaOFFSIDES
64Gamma-Glutamyltransferase IncreasedOFFSIDES
65Gastric mucosal lesionOFFSIDES
66Gastrointestinal endoscopic therapyOFFSIDES
67Gastrointestinal infectionOFFSIDES
68General physical health deteriorationOFFSIDES
69GlobulinuriaOFFSIDES
70HeadacheCanada Vigilance: 1Canada Vigilance
SIDER
71Heart sounds abnormalOFFSIDES
72HomicideCanada Vigilance: 1Canada Vigilance
73HostilitySIDER
74HypersensitivitySIDER
75Hypokalemia17092685CTD
76HypotensionCanada Vigilance: 1Canada Vigilance
SIDER
77IncontinenceSIDER
78Intention tremorOFFSIDES
79Intestinal ObstructionOFFSIDES
80Left Ventricular HypertrophyOFFSIDES
81LipaseOFFSIDES
82Liver transplant rejectionOFFSIDES
83MalnutritionSIDER
84Medical device implantationOFFSIDES
85Musculoskeletal discomfortOFFSIDES
86Mydriasis15919169CTD
87NauseaCanada Vigilance: 1Canada Vigilance
SIDER
88NegativismOFFSIDES
89Nervous tensionOFFSIDES
90NervousnessSIDER
91NoduleOFFSIDES
92OliguriaOFFSIDES
93OsteoporosisOFFSIDES
94OverdoseCanada Vigilance: 2Canada Vigilance
OFFSIDES
95Pain6133822CTD
96PalpitationsCanada Vigilance: 1Canada Vigilance
SIDER
97Pancreatic enzymes increasedOFFSIDES
98Pelvic venous thrombosisOFFSIDES
99Poisoning2993847CTD
100Product substitution issueCanada Vigilance: 1Canada Vigilance
101PruritusSIDER
102Pulmonary HypertensionOFFSIDES
103Pulmonary function test decreasedSIDER
104Respiratory DepressionSIDER
105Reticulocyte count decreasedOFFSIDES
106Retinal pigment epithelial tearOFFSIDES
107Retinoic acid syndromeOFFSIDES
108RhabdomyolysisOFFSIDES
109ScotomaOFFSIDES
110Seizures6133822CTD
111SinusitisOFFSIDES
112Small Intestinal StenosisOFFSIDES
113SomnolenceSIDER
114SubileusOFFSIDES
115Substance Withdrawal Syndrome6113557CTD
116Supraventricular tachycardiaOFFSIDES
117SynovitisOFFSIDES
118Tachycardia2483CTD
SIDER
119TensionSIDER
120ThrombophlebitisOFFSIDES
121ToxoplasmosisOFFSIDES
122TremorSIDER
123Upper respiratory tract inflammationOFFSIDES
124Urine output increasedOFFSIDES
125Venous InsufficiencyOFFSIDES
126VitrectomyOFFSIDES
127VomitingSIDER
128Vulvovaginal mycotic infectionOFFSIDES
129White blood cell count decreasedSIDER
130Wrong drug administeredOFFSIDES
131nervous system disorderSIDER
132prostatitisOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.